DNA testing speeds pneumonia diagnoses in COVID-19 patients
January 19, 2021 -- A new DNA test is helpful for making the diagnosis of secondary pneumonia in COVID-19 patients and treating them accordingly, U.K. researchers reported January 11 in the journal Critical Care.
Exact Sciences nabs license for TARDIS
January 16, 2021 -- Exact Sciences has acquired a worldwide exclusive license for targeted digital sequencing (TARDIS) technology from the Translational Genomics Research Institute.
Eurofins debuts new SARS-CoV-2 variant assay
January 15, 2021 -- Eurofins has launched a new SARS-CoV-2 assay and increased its capacity to detect and monitor new variants of the novel coronavirus.
ADA lowers optimal blood sugar levels for kids
January 15, 2021 -- The American Diabetes Association (ADA) has issued new guidelines for optimal A1C levels in pediatric patients with type 1 diabetes, lowering them to 7% hemoglobin A1C levels, instead of 7.5%, as per their 2019 guidelines.
I-calQ receives 9th patent for smartphone POC testing
January 15, 2021 -- Diagnostic developer I-calQ has received a ninth patent for its point-of-care (POC) testing technology, which can be used with most smartphones and can test for potentially hundreds of analytes or agents.
Sectra digital pathology goes live in Southern Denmark
January 14, 2021 -- A digital pathology system from Sectra has gone live in the Region of Southern Denmark, connecting lab medicine professionals at four hospitals that are geographically dispersed.
FDA clears PerkinElmer coronavirus test for asymptomatic use
January 14, 2021 -- PerkinElmer's New Coronavirus Nucleic Acid Detection kit has received an emergency use authorization from the U.S. Food and Drug Administration (FDA) for use in testing people who do not have symptoms of infection and where there is no other reason to suspect a positive result.
Paige raises $100M for digital pathology expansion
January 14, 2021 -- Digital pathology company Paige has raised $100 million in a series C financing round led by Casdin Capital and Johnson & Johnson Innovation.
MicroRNA blood test identifies severe malaria in children
January 13, 2021 -- A blood test for microRNAs shows promise for identifying children with severe forms of malaria and treating them accordingly, according to a new study published in Emerging Infectious Diseases, a journal of the U.S. Centers for Disease Control and Prevention.
BD sees Q1 revenues up 26% as COVID-19 testing drives sales
January 13, 2021 -- Becton Dickinson (BD) is projecting revenues for its fiscal first quarter to grow 26% as sales of COVID-19 testing products hit $865 million -- contributing 20 percentage points to revenue growth for the quarter.